A phase I study to evaluate the dosimetry and safety of [<sup>89</sup>Zr]Zr-DFO-AP-101, a new antibody-based radiopharmaceutical to detect misfolded SOD1 in amyotrophic lateral sclerosis. [PDF]
Croteau E +18 more
europepmc +1 more source
An international study of factors affecting variability of dosimetry calculations, part 5: impact of segmentation methods. [PDF]
Kurkowska S +5 more
europepmc +1 more source
Availability, accessibility, and economic feasibility of radionuclide therapies in Africa: a systematic review and quantitative infrastructure analysis. [PDF]
Ibrahim EA.
europepmc +1 more source
Personalised Dosimetry in Nuclear Medicine: Bridging Physics, Biology and AI for Next Generation Radiopharmaceutical Therapy. [PDF]
Shanmugiah J, Kim JS.
europepmc +1 more source
Population pharmacokinetic modeling in radiopharmaceutical therapy: a review. [PDF]
Hardiansyah D +2 more
europepmc +1 more source
In Vivo Studies of [<sup>161</sup>Tb]Tb-Trastuzumab Radiopharmaceutical Therapy in Human Epidermal Growth Factor Receptor 2-Expressing Breast Tumors Show High Tumor Uptake and Tumor Growth Suppression. [PDF]
Cold S +8 more
europepmc +1 more source
Strategic Objectives of Nanotechnology-Driven Repurposing in Radiopharmacy-Implications for Radiopharmaceutical Repurposing (Beyond Oncology). [PDF]
Salgueiro MJ, Zubillaga M.
europepmc +1 more source
Recent trends in the utilization of molecular breast imaging in the United States. [PDF]
Dave R +7 more
europepmc +1 more source
Fluorination augments tumor engagement and antitumor immunity of a D-peptide-based radiotheranostic agent for combinatorial immune checkpoint blockade therapy. [PDF]
Zhang S +15 more
europepmc +1 more source
Occupational radiation safety and sustainable workforce management in PET/CT practice: a pilot study of healthcare professionals in a newly established cyclotron-based nuclear medicine center. [PDF]
Marshall SK +4 more
europepmc +1 more source

